XML 51 R38.htm IDEA: XBRL DOCUMENT v3.23.3
Detail of Certain Accounts (Tables)
9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Cash and Cash Equivalents Amounts related to cash and cash equivalents held by consolidated or proportionately consolidated joint ventures and the captive insurance company, which are included in Quanta’s total cash and cash equivalents balances, were as follows (in thousands):
 September 30, 2023December 31, 2022
Cash and cash equivalents held by domestic joint ventures$34,684 $14,291 
Cash and cash equivalents held by foreign joint ventures8,188 6,277 
Total cash and cash equivalents held by joint ventures42,872 20,568 
Cash and cash equivalents held by captive insurance company21,758 35,085 
Cash and cash equivalents not held by joint ventures or captive insurance company240,725 372,852 
Total cash and cash equivalents$305,355 $428,505 
Accounts Payable and Accrued Expenses
Accounts payable and accrued expenses consisted of the following (in thousands):
 September 30, 2023December 31, 2022
Accounts payable, trade$1,990,788 $1,302,086 
Accrued compensation and related expenses582,136 469,048 
Other accrued expenses396,169 381,995 
Accounts payable and accrued expenses$2,969,093 $2,153,129